07 Jan 2001

Psorcutan® Salbe (Psorcutan® Salbe) - Deutschland

Updated: 07 Jan 2001

Psorcutan® Salbe

Leichte bis mittelschwere Psoriasis vom Plaque Typ.

Psorcutan® Salbe Description, Presentation and Dosage

Psorcutan® Salbe Description

Psorcutan® Salbe Drug Class Description

Einzelstoffe

Psorcutan® Salbe Drug Description

1 g enth.: Calcipotriol 0,05 mg.

Psorcutan® Salbe Generic Name

Psorcutan® Salbe

Psorcutan® Salbe Presentation

Psorcutan® Salbe Presentation

Psorcutan® Salbe

Psorcutan® Salbe Manufacturer

Schering/Asche

Related Learning Zones

Hypogonadism Knowledge Centre

Hypogonadism Knowledge Centre

The Hypogonadism Knowledge Centre provides healthcare professionals with free access to disease awareness sections such as epidemiology, pathophysiology, signs and symptoms, treatment options to assist the process of diagnosis, treatment and monitoring of patients with the condition. The regularly updated publications digest area contains analysis and comment on recent scientific articles related to male hypogonadism.

G.MKT.GM.MH.01.2016.0364

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis Knowledge Centre

IL-17A in Psoriasis is intended for healthcare professionals involved in the treatment and management of patients with psoriasis. This resource has been developed primarily to discuss the role of the IL-17 pathway in the pathogenesis of psoriasis and the therapeutic potential of treatments directed towards IL-17A. Users can expect to find sections containing expert videos, clinical slide decks, congress highlights, key publications and links to useful resources.

This resource has been developed in collaboration with Novartis Pharma AG.

Psorcutan® Salbe Dosage

Psorcutan® Salbe Adult Dosage

Wasser-Öl-Emulsion, gereinigtes Wasser, Dinatriumedetat 2H2O, Natriummonohydrogenphosphat 2H2O, 'alpha'-Tocopherol, dickflüssiges Paraffin, 'alpha'-Octadecyl-'omega'-hydroxypoly(oxyethylen)-2, Propylenglycol, weißes Vaselin.

Psorcutan® Salbe Precautions, Reactions and Contraindications

Psorcutan® Salbe Special Precautions

Psorcutan® Salbe Special Precautions

Anw. auf größeren Hautflächen als max. 30% d. Körpers. Psoriasis punctata, Psoriasis pustulosa, schwere Nieren- o. Lebererkrank. b. allen Erkrank. die m. Veränd. d. Kalziumstoffwechsels einhergehen, i. Gesicht u. auf d. behaarten Kopf, b. Pers. unter 18 Jahren.

Psorcutan® Salbe Adverse Reactions

Psorcutan® Salbe Adverse Reactions

Kontraind. Gr 4 .

Related Drugs - Dermatology

Back to top